HIV/AIDS
Rwanda: MSF welcomes the release of WHO guidelines for HIV prevention drug, lenacapavir
Uncertainty around PEPFAR program puts millions of people at risk
Malawi: “In 2001, when the counsellor said ART could prolong my life, I thought it would be two to three years but here I am, 22 years later”
Pharmaceutical corporation ViiV must improve its failing access strategy for lifesaving HIV prevention drug
Pharmaceutical corporation ViiV must make ground-breaking HIV prevention injection affordable and available
HIV/AIDS in the DRC: Behind the progress, huge challenges remain
HIV/AIDS: AIDS death toll stagnating due to lack of testing at community level
